Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 HKD | +1.59% | +6.44% | +22.49% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
Evolution of the average Target Price on Everest Medicines Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Everest Medicines Limited
Nomura |
EPS Revisions
- Stock Market
- Equities
- 1952 Stock
- Consensus Everest Medicines Limited